Claudia L. Kleinman

Claudia L. Kleinman

Auto-generated profile, based on publicly available information

Claudia L. Kleinman

Lady Davis Research Institute, Jewish General Hospital, Montréal, Canada

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 November 2019 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
SJSelin Jessa
Selin Jessa
ABAlexis Blanchet-Cohen
Alexis Blanchet-Cohen
BKBrian Krug
Brian Krug
MVMaria Vladoiu
Maria Vladoiu
MCMarie Coutelier
Marie Coutelier
CKClaudia L. Kleinman
Claudia L. Kleinman

1 November 2017 in Cancer Cell
Verified
Journal Article
Closed access
MPManav Pathania
Manav Pathania
NJNicolas De Jay
Nicolas De Jay
NMNicola Maestro
Nicola Maestro
AHAshot S. Harutyunyan
Ashot S. Harutyunyan
JNJustyna Nitarska
Justyna Nitarska
PSPaolo Salomoni
Paolo Salomoni

1 May 2019 in Cancer Cell
Verified
Journal Article
Closed access
BKBrian Krug
Brian Krug
NJNicolas De Jay
Nicolas De Jay
AHAshot S. Harutyunyan
Ashot S. Harutyunyan
SDShriya Deshmukh
Shriya Deshmukh
DMDylan M. Marchione
Dylan M. Marchione
SMStephen C. Mack
Stephen C. Mack

8 December 2013 in Nature Genetics
Verified
Journal Article
Closed access
CKClaudia L Kleinman
Claudia L Kleinman
NGNoha Gerges
Noha Gerges
SPSimon Papillon-Cavanagh
Simon Papillon-Cavanagh
PSPatrick Sin-Chan
Patrick Sin-Chan
APAlbena Pramatarova
Albena Pramatarova
NJNada Jabado
Nada Jabado

15 November 2012 in PLOS Genetics
Verified
Journal Article
Open access
PDF file
YBYves B Beaulieu
Yves B Beaulieu
CKClaudia L Kleinman
Claudia L Kleinman
ALAnne-Marie Landry-Voyer
Anne-Marie Landry-Voyer
JMJacek Majewski
Jacek Majewski
FBFrançois Bachand
François Bachand
The poly(A)-binding protein nuclear 1 (PABPN1) is a ubiquitously expressed protein that is thought to function during mRNA poly(A) tail synthesis in the nucleus. Despite the predicted role of PABPN1 in mRNA polyadenylation, little is known about the impact of PABPN1 deficiency on human gene expression. Specifically, it remains unclear whether PABPN1 is required for general mRNA expression or for the regulation of specific transcripts. Using RNA sequencing (RNA–seq), we show here that the large majority of protein-coding genes express normal levels of mRNA in PABPN1–deficient cells, arguing that PABPN1 may not be required for the bulk of mRNA expression. Unexpectedly, and contrary to the view that PABPN1 functions exclusively at protein-coding genes, we identified a class of PABPN1–sensitive long noncoding RNAs (lncRNAs), the majority of which accumulated in conditions of PABPN1 deficiency. Using the spliced transcript produced from a snoRNA host gene as a model lncRNA, we show that PABPN1 promotes lncRNA turnover via a polyadenylation-dependent mechanism. PABPN1–sensitive lncRNAs are targeted by the exosome and the RNA helicase MTR4/SKIV2L2; yet, the polyadenylation activity of TRF4-2, a putative human TRAMP subunit, appears to be dispensable for PABPN1–dependent regulation. In addition to identifying a novel function for PABPN1 in lncRNA turnover, our results provide new insights into the post-transcriptional regulation of human lncRNAs. In eukaryotic cells, protein-coding genes are transcribed to produce pre-messenger RNAs (pre–mRNAs) that are processed at the 3′ end by the addition of a sequence of poly-adenosine. This 3′ end poly(A) tail normally confers positive roles to the mRNA life cycle by stimulating nuclear export and translation. The fundamental role of mRNA polyadenylation is generally mediated by the activity of poly(A)-binding proteins (PABPs) that bind to the 3′ poly(A) tail of eukaryotic mRNAs. In the nucleus, the evolutionarily conserved poly(A)-binding protein PABPN1 is thought to be important for gene expression, as it stimulates mRNA polyadenylation in biochemical assays. Using a high-throughput sequencing approach that quantitatively measures the level of RNA expressed from all genes, we addressed the global impact of a PABPN1 deficiency on human gene expression. Notably, we found that most mRNAs were normally expressed in PABPN1–deficient cells, a result inconsistent with a role for PABPN1 in general mRNA metabolism. Surprisingly, our genome-wide analysis unveiled a new function for PABPN1 in a polyadenylation-dependent pathway of RNA decay that targets non-protein coding genes. Our discovery that PABPN1 functions in the regulation of noncoding RNAs raises the possibility that oculopharyngeal muscular dystrophy, a disease associated with mutations in the PABPN1 gene, is caused by defective expression of noncoding RNAs.

14 December 2016 in EMBO Reports
Verified
Journal Article
Closed access
PDF file
HAHana Antonicka
Hana Antonicka
KCKarine Choquet
Karine Choquet
ZLZhen‐Yuan Lin
Zhen‐Yuan Lin
AGAnne‐Claude Gingras
Anne‐Claude Gingras
CKClaudia L Kleinman
Claudia L Kleinman
ESEric A Shoubridge
Eric A Shoubridge